References
Förstl H., Burns A., Luthert P., Cairns N., Levy R.:The Lewy body variant of Alzheimer's disease. Clinical and pathological findings. British J. Psychiatry 162: 385–392, 1993.
Lennox G., Lowe J., Morrell K., Landon M., Mayer R.J.:Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J. Neurol. Neurosurg. Psychiatry 52: 67–71, 1989.
Liberini P., Valerio A., Memo M., Spano P.F.:Lewybody dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease? TiPS 17, 556–561, 1996.
McKeith I.G., Galasko D., Kosaka K. et al.:Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113–1124, 1996.
Perry R.H., Irving D., Blessed G., Fairbairn A., Perry E.K.:Senile dementia of the Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J. Neurol. Sci. 95: 119–139, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liberini, P. Criteria for the clinical diagnosis of dementia with Lewy bodies. Ital J Neuro Sci 18, 61 (1997). https://doi.org/10.1007/BF02106235
Issue Date:
DOI: https://doi.org/10.1007/BF02106235